Investigation of Toxoplasma gondii Seropositivity in Uludağ University Hospital between 2009-2016

Abstract

The aim of this study is to investigate the distribution of anti-Toxoplasma gondii immunoglobulin G (IgG) and immünoglobulin M (IgM) antibodies in patients with suspected toxoplasmosis admitted to the Practice and Research Center of Health of the Medical Faculty of Uludağ University. The blood samples examined for the presence of anti-T. gondii IgG antibody and anti-T. gondii IgM antibody by an enzyme linked fluorescent assay test, anti-T. gondii IgG avidity value was evaluated by VIDAS (BioMérieux, France) kit. In our study, anti-T. gondii IgG seropositivity in 3311 (30.7%) of 10.603 cases and anti-T. gondii IgM seropositivity in 1423 (9.7%) of 14.618 cases were detected. Seropositivity of anti-T. gondii IgG was 37.5% in women of childbearing age group. The avidity value was high in 56.1% (n=156) and low in 28.9% (n=80) of childbearing age group women with positive anti-T. gondii IgG and anti-T. gondii IgM test. Especially in regions where seroprevalence is high, we think that pregnant women and women of childbearing age should be investigated in terms of T. gondii antibodies.